MedTrace Logo

Effect of Sars-cov-2 on Donor Oocyte Quality and Quantity, a Multicenter Retrospective Study.

NCT05562479 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 428

Last updated 2022-10-05

No results posted yet for this study

Summary

Purpose: To determine the impact of SARS-CoV-2 infection and immunization on ovarian response to controlled ovarian stimulation (COS) and embryo development after in vitro fertilization (IVF) Methods: A retrospective multicentric cohort study of 427 oocyte donors was conducted between January 1st, 2018 and September 18th, 2022. Patients who recovered from SARS-CoV-2 infection, vaccinated or non-exposed were included. Demographic, cycle characteristics, and laboratory outcomes were compared.

Conditions

Interventions

BIOLOGICAL

Sars Cov 2 infection

Donors recovered from Sars Cov 2 Infection

BIOLOGICAL

Sars Cov 2 vaccination

Egg Donors vaccinated

Sponsors & Collaborators

  • Novafem

    lead OTHER

Principal Investigators

  • Jose A Moreno, PhD · Universitat Autonoma de Barcelona

Eligibility

Min Age
18 Years
Max Age
32 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-12
Primary Completion
2022-07-15
Completion
2022-09-18

Countries

  • Colombia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05562479 on ClinicalTrials.gov